Ceribell Share Price (NASDAQ: CBLL)

$11.84

▲

-0.13

(-1.09%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Ceribell Stock chart to analyse performance

Ceribell stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$11.75
Today's High:$11.99
$11.84
0.76%
Downside
Day's Volatility :2.0%
Upside
1.25%
52 Weeks Low:$10.01
52 Weeks High:$32.75
$11.84
15.46%
Downside
52 Weeks Volatility :69.43%
Upside
63.85%

Ceribell Stock Returns

Period	Ceribell	Index (Russel 2000)
3 Months	-31.14%	0.0%
6 Months	-51.95%	0.0%
1 Year	-52.68%	0.0%
3 Years	-52.68%	-4.7%

Ceribell Key Stats

Check Ceribell key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$11.97
Open	$11.905
Today's High	$11.99
Today's Low	$11.75
Market Capitalization	$768.1M
Today's Volume	$226.0K
52 Week High	$32.7489
52 Week Low	$10.01
Revenue TTM	$60.0M
EBITDA	$-34.2M
Earnings Per Share (EPS)	$-1.06
Profit Margin	-60.21%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

Stock Returns calculator for Ceribell Stock including INR - Dollar returns

The Ceribell stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ceribell investment value today

Current value as on today

₹52,644

Returns

₹47,356

(-47.36%)

Returns from Ceribell Stock

₹52,640 (-52.64%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Ceribell Stock

-87%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Ceribell Stock from India on INDmoney has decreased by -87% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Ceribell Stock

Rating

Trend

Ceribell Share Price Target

What analysts predicted

Upside of 180.83%

Target:

$33.25

Current:

$11.84

Ceribell share price target is $33.25, a slight Upside of 180.83% compared to current price of $11.84 as per analysts' prediction.

Ceribell Stock Insights

Price Movement
In the last 1 month, CBLL stock has moved down by -20.7%

Ceribell Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY22

FY23

FY24

	FY22	Y/Y Change
Revenue	$25.9M	-
Net Income	$-37.2M	-
Net Profit Margin	-143.37%	-

	FY23	Y/Y Change
Revenue	$45.2M	↑ 74.47%
Net Income	$-29.5M	↓ 20.72%
Net Profit Margin	-65.15%	↑ 78.22%

	FY24	Y/Y Change
Revenue	$65.4M	↑ 44.71%
Net Income	$-40.5M	↑ 37.3%
Net Profit Margin	-61.82%	↑ 3.33%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$14.9M	↑ 13.15%
Net Income	$-8.7M	↑ 5.52%
Net Profit Margin	-58.76%	↑ 4.25%

	Q2 FY24	Q/Q Change
Revenue	$14.9M	↑ 0.0%
Net Income	$-8.7M	↑ 0.0%
Net Profit Margin	-58.76%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$17.2M	↑ 15.73%
Net Income	$-10.4M	↑ 19.31%
Net Profit Margin	-60.58%	↓ 1.82%

	Q4 FY24	Q/Q Change
Revenue	$18.5M	↑ 7.79%
Net Income	$-12.6M	↑ 20.73%
Net Profit Margin	-67.85%	↓ 7.27%

	Q1 FY25	Q/Q Change
Revenue	$20.5M	↑ 10.56%
Net Income	$-12.8M	↑ 1.6%
Net Profit Margin	-62.35%	↑ 5.5%

	Q2 FY25	Q/Q Change
Revenue	$21.2M	↑ 3.46%
Net Income	$-13.6M	↑ 6.78%
Net Profit Margin	-64.36%	↓ 2.01%

FY22

FY23

FY24

	FY22	Y/Y Change
Profit	$21.5M	-

	FY23	Y/Y Change
Profit	$38.2M	↑ 77.57%

	FY24	Y/Y Change
Profit	$56.8M	↑ 48.7%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$12.8M	↑ 14.7%

	Q2 FY24	Q/Q Change
Profit	$12.8M	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$15.0M	↑ 17.73%

	Q4 FY24	Q/Q Change
Profit	$16.2M	↑ 8.17%

	Q1 FY25	Q/Q Change
Profit	$18.0M	↑ 10.89%

	Q2 FY25	Q/Q Change
Profit	$18.7M	↑ 3.75%

FY22

FY23

FY24

	FY22	Y/Y Change
Operating Cash Flow	$-32.0M	-
Investing Cash Flow	$-1.4M	-
Financing Cash Flow	$49.8M	-

	FY23	Y/Y Change
Operating Cash Flow	$-29.2M	↓ 8.88%
Investing Cash Flow	$-1.8M	↑ 26.02%
Financing Cash Flow	$-2.8M	↓ 105.66%

	FY24	Y/Y Change
Operating Cash Flow	$-35.0M	↑ 20.18%
Investing Cash Flow	$-1.6M	↓ 9.36%
Financing Cash Flow	$196.5M	↓ 7073.6%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-8.3M	↑ 23.79%
Investing Cash Flow	$-644.0K	↓ 5.71%
Financing Cash Flow	$3.8M	↓ 210.86%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-8.3M	↑ 0.0%
Investing Cash Flow	$-644.0K	↑ 0.0%
Financing Cash Flow	$3.8M	↑ 0.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-8.5M	↑ 3.38%
Investing Cash Flow	$183.0K	↓ 128.42%
Financing Cash Flow	$-1.9M	↓ 149.19%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-10.0M	↑ 16.78%
Investing Cash Flow	$-493.0K	↓ 369.4%
Financing Cash Flow	$190.7M	↓ 10202.12%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-11.4M	↑ 14.32%
Investing Cash Flow	$-29.6M	↑ 5905.88%
Financing Cash Flow	$2.0K	↓ 100.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-7.5M	↓ 33.94%
Investing Cash Flow	$-107.7M	↑ 263.71%
Financing Cash Flow	$2.0M	↑ 100200.0%

Ceribell Technicals Summary

Sell

Neutral

Buy

Ceribell is currently in a neutral trading position according to technical analysis indicators.

Ceribell Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ceribell	-17.85%	-51.95%	-52.68%	-52.68%	-52.68%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ceribell	NA	NA	NA	-2.05	0.0	0.0	NA	-23.53
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ceribell	NA	$768.1M	-52.68%	NA	-60.21%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Ceribell

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Organization	Ceribell
Employees	281
CEO	Dr. Xingjuan Chao Ph.D.
Industry	Miscellaneous

Key Management of Ceribell

Name	Title
Dr. Xingjuan Chao Ph.D.	Co-Founder, President, CEO & Director
Dr. Josef Parvizi M.D., Ph.D.	Co-Founder, Chief Medical Advisor & Director
Mr. Scott Blumberg	Chief Financial Officer
Dr. Raymond Woo Ph.D.	Chief Technology Officer
Mr. Dan Rogy	Senior Vice President of Operations
Ms. Louisa Daniels J.D., M.B.A.	General Counsel
Mr. Brian P. Price	Senior Vice President of Marketing
Ms. Baharan Kamousi Ph.D.	Senior Vice President of Data Science
Mr. Sean Manni	Chief Revenue Officer
Mr. David Foehr	Senior Vice President of Finance

Important FAQs about investing in CBLL Stock from India :

What is Ceribell share price today?

Ceribell share price today is $11.84 as on August 30, 2025 at 1:29 am IST at the close of the market. Ceribell share today touched a day high of $11.99 and a low of $11.75.

What is the 52 week high and 52 week low for Ceribell share?

Ceribell share touched a 52 week high of $32.75 and a 52 week low of $10.01. Ceribell stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $11.84, lower by 63.85% versus the 52 week high.

How to invest in Ceribell Stock (CBLL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ceribell on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ceribell Shares that will get you 0.1267 shares as per Ceribell share price of $11.84 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ceribell Stock (CBLL) from India?

Indian investors can start investing in Ceribell (CBLL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Ceribell stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Ceribell share’s latest price of $11.84 as on August 30, 2025 at 1:29 am IST, you will get 0.8446 shares of Ceribell. Learn more about fractional shares .

What are the returns that Ceribell has given to Indian investors in the last 5 years?

Ceribell stock has given -52.68% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?